{"id":10003,"date":"2026-01-26T23:02:39","date_gmt":"2026-01-26T23:02:39","guid":{"rendered":"https:\/\/mailitics.com\/index.php\/2026\/01\/26\/biotech-news-wegovy-pill-launch-holds-promise-novo-nordisk\/"},"modified":"2026-01-26T23:02:39","modified_gmt":"2026-01-26T23:02:39","slug":"biotech-news-wegovy-pill-launch-holds-promise-novo-nordisk","status":"publish","type":"post","link":"https:\/\/mailitics.com\/index.php\/2026\/01\/26\/biotech-news-wegovy-pill-launch-holds-promise-novo-nordisk\/","title":{"rendered":"STAT+: Launch of Wegovy pill looks to be going strong so far"},"content":{"rendered":"

STAT+: Launch of Wegovy pill looks to be going strong so far
\n \t

\n
<\/BR>
\n
\n \t

\n
<\/BR><\/p>\n

\n

Want to stay on top of the science and politics driving biotech today?\u00a0Sign up<\/a>\u00a0to get our biotech newsletter in your inbox.<\/em><\/p>\n

Morning! Today, we see a new synthetic biology startup, backed by Frances Arnold and Bob Langer. Plus, it\u2019s still early, but Novo Nordisk already appears to be having a robust rollout\u00a0of the Wegovy pill.<\/p>\n

New FDA pathway brings promise, and concerns<\/h2>\n

Bioethicists including the University of Pennsylvania\u2019s Holly Fernandez Lynch support the FDA\u2019s push to create a new approval pathway for personalized gene-editing treatments like the one given to Baby KJ<\/a>. But, in an interview with STAT\u2019s Jason Mast, she warned that the \u201cplausible mechanism\u201d framework laid out by FDA Commissioner Marty Makary and CBER chief Vinay Prasad is legally murky \u2014 and could be dangerously open-ended.<\/p>\n

Continue to STAT+ to read the full story\u2026<\/a><\/p>\n<\/div>\n

\t

\n
<\/BR>
\n Meghana Keshavan
\n \t

\n
<\/BR>
\nGo to statnews<\/a>
\n \t

\n
<\/BR><\/p>\n","protected":false},"excerpt":{"rendered":"

STAT+: Launch of Wegovy pill looks to be going strong so far Want to stay on top of the science and politics driving biotech today?\u00a0Sign up\u00a0to get our biotech newsletter in your inbox. Morning! Today, we see a new synthetic biology startup, backed by Frances Arnold and Bob Langer. Plus, it\u2019s still early, but Novo […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2194,2154,58,2208,2209,2176,858,2207],"tags":[2150],"class_list":["post-10003","post","type-post","status-publish","format-standard","hentry","category-biotech","category-biotechnology","category-business","category-drug-development","category-drug-prices","category-pharma","category-research","category-the-readout","tag-statnews"],"_links":{"self":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/10003"}],"collection":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/comments?post=10003"}],"version-history":[{"count":0,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/10003\/revisions"}],"wp:attachment":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/media?parent=10003"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/categories?post=10003"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/tags?post=10003"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}